Company registration number SC725145 (Scotland)
TARGET HEALTHCARE (WHOLESALE) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
TARGET HEALTHCARE (WHOLESALE) LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2
Notes to the financial statements
4 - 10
TARGET HEALTHCARE (WHOLESALE) LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr L Campbell
Mr S Duncan
Company number
SC725145
Registered office
8 Redwood Crescent
East Kilbride
United Kingdom
G74 5PA
Auditor
Consilium Audit Limited
169 West George Street
Glasgow
Scotland
G2 2LB
TARGET HEALTHCARE (WHOLESALE) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
5
2,620
5,200
Tangible assets
6
196,284
146,409
198,904
151,609
Current assets
Stocks
-
1,449,395
Debtors
7
1,292,230
3,706,380
Cash at bank and in hand
358,879
867,096
1,651,109
6,022,871
Creditors: amounts falling due within one year
8
(5,083,806)
(6,801,262)
Net current liabilities
(3,432,697)
(778,391)
Total assets less current liabilities
(3,233,793)
(626,782)
Provisions for liabilities
(42,871)
(34,942)
Net liabilities
(3,276,664)
(661,724)
Capital and reserves
Called up share capital
10
1
1
Profit and loss reserves
(3,276,665)
(661,725)
Total equity
(3,276,664)
(661,724)
The notes on pages 4 to 10 form part of these financial statements.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 7 August 2025 and are signed on its behalf by:
Mr L Campbell
Director
Company Registration No. SC725145
TARGET HEALTHCARE (WHOLESALE) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2023
1
1
Year ended 31 December 2023:
Loss and total comprehensive income for the year
-
(661,725)
(661,725)
Balance at 31 December 2023
1
(661,725)
(661,724)
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
(2,614,940)
(2,614,940)
Balance at 31 December 2024
1
(3,276,665)
(3,276,664)
The notes on pages 4 to 10 form part of these financial statements.
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
1
Accounting policies
Company information
Target Healthcare (Wholesale) Limited is a private company limited by shares incorporated in Scotland. The registered office is 8 Redwood Crescent, East Kilbride, United Kingdom, G74 5PA. The company's registration number is SC725145.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
The company is dependent on the ongoing support of Target Healthcare Group Limited, the immediate parent company, to provide funds to meet its debts and other financial obligations as they fall due. Target Healthcare Group Limited has pledged its support to the company to enable it to continue in operational existence for the foreseeable future. In view of this, the directors are satisfied that it is appropriate to prepare the accounts on a going concern basis.true
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Intangible fixed assets other than goodwill
Intangible assets comprise software related costs. These intangibles are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Other
20% straight line
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
20% straight line
Fixtures and fittings
20% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit and loss account.
1.6
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.7
Stocks
Inventories are stated at lower of cost and net realisable value. In determining the cost of raw materials, consumables and goods purchased for resale, the weighted average purchase price is used. For work in progress and finished goods cost is taken as production cost, which includes an appropriate proportion of attributable overheads.
1.8
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.10
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.11
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.12
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 7 -
1.13
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.14
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to the profit and loss account on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
2
Operating loss
2024
2023
Operating loss for the year is stated after charging:
£
£
Depreciation of owned tangible fixed assets
39,111
5,647
Amortisation of intangible assets
330
-
Operating lease charges
190,154
127,984
3
Auditor's remuneration
Auditors remuneration is borne by a fellow group entity.
4
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Total
34
47
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
5
Intangible fixed assets
Other
£
Cost
At 1 January 2024
5,200
Other changes
(2,250)
At 31 December 2024
2,950
Amortisation and impairment
At 1 January 2024
Amortisation charged for the year
330
At 31 December 2024
330
Carrying amount
At 31 December 2024
2,620
At 31 December 2023
5,200
6
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 January 2024
20,050
132,006
152,056
Additions
88,986
88,986
At 31 December 2024
20,050
220,992
241,042
Depreciation and impairment
At 1 January 2024
668
4,979
5,647
Depreciation charged in the year
4,010
35,101
39,111
At 31 December 2024
4,678
40,080
44,758
Carrying amount
At 31 December 2024
15,372
180,912
196,284
At 31 December 2023
19,382
127,027
146,409
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
7
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
1,180,140
3,087,790
Amounts owed by group undertakings
50,639
460,637
Other debtors
61,451
157,953
1,292,230
3,706,380
8
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
495,564
2,431,457
Amounts owed to group undertakings
2,608,998
Taxation and social security
171,280
172,944
Other creditors
1,807,964
4,196,861
5,083,806
6,801,262
Included within other creditors is an invoice discounting facility of £1,477,551 (2023: £3,376,118). This is secured by a fixed charge over the purchased debts and a floating charge over all assets and undertakings.
9
Deferred taxation
The following are the major deferred tax liabilities recognised by the company and movements thereon:
2024
2023
Balances:
£
£
Accelerated capital allowances
43,884
36,063
Short term timing differences
(1,013)
(1,121)
42,871
34,942
2024
Movements in the year:
£
Liability at 1 January 2024
34,942
Charge to profit or loss
7,929
Liability at 31 December 2024
42,871
TARGET HEALTHCARE (WHOLESALE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
10
Called up share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
1 Ordinary shares of £1
1
1
11
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:
The auditor's report was unqualified.
Senior Statutory Auditor:
David Holt
Statutory Auditor:
Consilium Audit Limited
12
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2024
2023
£
£
82,525
107,060
13
Related party transactions
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
No further transactions with related parties were undertaken such as are required to be disclosed under the provisions of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
14
Ultimate controlling party
The Company is a wholly owned subsidiary of Target Healthcare Group Limited. The company is included within the consolidated financial statements of Target Healthcare Holdings Group Limited, available at the registered address 8 Redwood Crescent, East Kilbride, Glasgow, Scotland, G74 5PA.
The ultimate parent company is Target Healthcare Group Limited, a company registered in the Isle of Man. No consolidated accounts are required at this level.
The ultimate controlling party is L Campbell.
2024-12-312024-01-01falsefalsefalse13 August 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMr L CampbellMr S DuncanMrs G GrantSC7251452024-01-012024-12-31SC725145bus:Director12024-01-012024-12-31SC725145bus:Director22024-01-012024-12-31SC725145bus:Director32024-01-012024-12-31SC725145bus:RegisteredOffice2024-01-012024-12-31SC7251452024-12-31SC7251452023-12-31SC725145core:IntangibleAssetsOtherThanGoodwill2024-12-31SC725145core:IntangibleAssetsOtherThanGoodwill2023-12-31SC725145core:PlantMachinery2024-12-31SC725145core:FurnitureFittings2024-12-31SC725145core:PlantMachinery2023-12-31SC725145core:FurnitureFittings2023-12-31SC725145core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-31SC725145core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-31SC725145core:CurrentFinancialInstruments2024-12-31SC725145core:CurrentFinancialInstruments2023-12-31SC725145core:ShareCapital2024-12-31SC725145core:ShareCapital2023-12-31SC725145core:RetainedEarningsAccumulatedLosses2024-12-31SC725145core:RetainedEarningsAccumulatedLosses2023-12-31SC725145core:ShareCapital2022-12-31SC725145core:RetainedEarningsAccumulatedLosses2022-12-31SC725145core:ShareCapitalOrdinaryShareClass12024-12-31SC725145core:ShareCapitalOrdinaryShareClass12023-12-31SC725145core:RetainedEarningsAccumulatedLosses2023-01-012023-12-31SC7251452023-01-012023-12-31SC725145core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31SC725145core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31SC725145core:ComputerSoftware2024-01-012024-12-31SC725145core:PlantMachinery2024-01-012024-12-31SC725145core:FurnitureFittings2024-01-012024-12-31SC725145core:IntangibleAssetsOtherThanGoodwill2023-12-31SC725145core:PlantMachinery2023-12-31SC725145core:FurnitureFittings2023-12-31SC7251452023-12-31SC725145core:WithinOneYear2024-12-31SC725145core:WithinOneYear2023-12-31SC725145bus:PrivateLimitedCompanyLtd2024-01-012024-12-31SC725145bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-31SC725145bus:FRS1022024-01-012024-12-31SC725145bus:Audited2024-01-012024-12-31SC725145bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP